[1] |
Gordon AA, Danek DJ, Phelps PO. Common inflammatory and infectious conditions of the eyelid. Dis Mon, 2020; 66, 101042. doi: 10.1016/j.disamonth.2020.101042 |
[2] |
Bragg KJ, Le PH, Le JK. Hordeolum. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2020, StatPearls Publishing LLC. 2020. |
[3] |
Lindsley K, Nichols JJ, Dickersin K. Interventions for acute internal hordeolum. Cochrane Database Syst Rev, 2013; 4, CD007742. |
[4] |
Lindsley K, Nichols JJ, Dickersin K. Non-surgical interventions for acute internal hordeolum. Cochrane Database Syst Rev, 2017; 1, CD007742. |
[5] |
Maldonado MJ, Juberías JR, Moreno-Montañés J. Extensive corneal epithelial defect associated with internal hordeolum after uneventful laser in situ keratomileusis. J Cataract Refract Surg, 2002; 28, 1700−2. doi: 10.1016/S0886-3350(01)01271-8 |
[6] |
Cheng K, Law A, Guo MH, et al. Acupuncture for acute hordeolum. Cochrane Database Syst Rev, 2017; 2, CD011075. |
[7] |
Babilas P, Schreml S, Szeimies RM, et al. Intense pulsed light (IPL): a review. Lasers Surg Med, 2010; 42, 93−104. doi: 10.1002/lsm.20877 |
[8] |
Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol, 2015; 26, 314−8. doi: 10.1097/ICU.0000000000000166 |
[9] |
Craig JP, Chen YH, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci, 2015; 56, 1965−70. doi: 10.1167/iovs.14-15764 |
[10] |
Xue AL, Wang MTM, Ormonde SE, et al. Randomised double-masked placebo-controlled trial of the cumulative treatment efficacy profile of intense pulsed light therapy for meibomian gland dysfunction. Ocul Surf, 2020; 18, 286−97. doi: 10.1016/j.jtos.2020.01.003 |
[11] |
Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf, 2019; 17, 104−10. doi: 10.1016/j.jtos.2018.11.004 |
[12] |
Wladis EJ, Aakalu VK, Foster JA, et al. Intense pulsed light for meibomian gland disease: a report by the American academy of ophthalmology. Ophthalmology, 2020; 127, 1227−33. doi: 10.1016/j.ophtha.2020.03.009 |
[13] |
Ruan F, Zang YX, Sella R, et al. Intense pulsed light therapy with optimal pulse technology as an adjunct therapy for moderate to severe blepharitis-associated keratoconjunctivitis. J Ophthalmol, 2019; 2019, 3143469. |
[14] |
Lyons AB, Townsend SM, Turk D, et al. Laser and light-based treatment modalities for the management of hidradenitis suppurativa. Am J Clin Dermatol, 2020; 21, 237−43. doi: 10.1007/s40257-019-00491-1 |
[15] |
Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg, 2015; 33, 41−6. doi: 10.1089/pho.2014.3819 |
[16] |
Taylor M, Porter R, Gonzalez M. Intense pulsed light may improve inflammatory acne through TNF-α down-regulation. J Cosmet Laser Ther, 2014; 16, 96−103. doi: 10.3109/14764172.2013.864198 |
[17] |
Jiang XD, Lv HB, Song H, et al. Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J Ophthalmol, 2016; 2016, 1910694. |
[18] |
Zhu Q, Xiao SY, Hua ZJ, et al. Near infrared (NIR) light therapy of eye diseases: a review. Int J Med Sci, 2021; 18, 109−19. doi: 10.7150/ijms.52980 |
[19] |
Dell SJ. Intense pulsed light for evaporative dry eye disease. Clin Ophthalmol, 2017; 11, 1167−73. doi: 10.2147/OPTH.S139894 |
[20] |
Han JY, Lee Y, Nam S, et al. Effect of intense pulsed light using acne filter on eyelid margin telangiectasia in moderate-to-severe meibomian gland dysfunction. Lasers Med Sci, 2022; 37, 2185−92. doi: 10.1007/s10103-021-03482-z |
[21] |
Ryu SI, Suh DH, Lee SJ, et al. Efficacy and safety of intense pulsed light using a dual-band filter for the treatment of facial acne vulgaris. Lasers Med Sci, 2022; 37, 531−6. doi: 10.1007/s10103-021-03292-3 |
[22] |
Roberts WE. Skin type classification systems old and new. Dermatol Clin, 2009; 27, 529−33. |
[23] |
Hawker GA, Mian S, Kendzerska T, et al. Measures of adult pain: visual analog scale for pain (VAS Pain), numeric rating scale for pain (NRS Pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res, 2011; 63, S240−52. doi: 10.1002/acr.20543 |
[24] |
Larsen SDH, Heegaard S, Toft PB. Histological and clinical evaluation of the hard palate mucous membrane graft for treatment of lower eyelid retraction. Acta Ophthalmol, 2017; 95, 295−8. doi: 10.1111/aos.13321 |
[25] |
Tan J, Liu H, Leyden JJ, et al. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol, 2014; 71, 760−3. doi: 10.1016/j.jaad.2014.05.044 |
[26] |
Yan XM, Hong J, Jin XM, et al. The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial. Eye Contact Lens, 2021; 47, 45−53. doi: 10.1097/ICL.0000000000000711 |
[27] |
Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea, 2008; 27, 1142−7. doi: 10.1097/ICO.0b013e3181814cff |
[28] |
Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea, 1998; 17, 38. doi: 10.1097/00003226-199801000-00007 |
[29] |
Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye, 1991; 5, 395−411. doi: 10.1038/eye.1991.65 |
[30] |
Srinivasan S, Menzies K, Sorbara L, et al. Infrared imaging of meibomian gland structure using a novel keratograph. Optom Vis Sci, 2012; 89, 788−94. doi: 10.1097/OPX.0b013e318253de93 |
[31] |
Amparo F, Wang HB, Yin J, et al. Evaluating corneal fluorescein staining using a novel automated method. Invest Ophthalmol Vis Sci, 2017; 58, BIO168−73. doi: 10.1167/iovs.17-21831 |
[32] |
Rosner B, Glynn RJ, Lee MLT. Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics, 2003; 59, 1089−98. doi: 10.1111/j.0006-341X.2003.00125.x |
[33] |
Carlisle RT, Digiovanni J. Differential diagnosis of the swollen red eyelid. Am Fam Physician, 2015; 92, 106−12. |
[34] |
George JL. Eyelid pathology: stye, chalazion, ectropion, entropion. Diagnosis. Rev Prat, 1990; 40, 1619−20. |
[35] |
McAlinden C, González-Andrades M, Skiadaresi E. Hordeolum: Acute abscess within an eyelid sebaceous gland. Cleve Clin J Med, 2016; 83, 332−4. doi: 10.3949/ccjm.83a.15012 |
[36] |
Akal A, Goncu T, Kocarslan S, et al. Hemorrhagic pyogenic granuloma after internal hordeolum. Int J Crit Illn Inj Sci, 2014; 4, 317−8. doi: 10.4103/2229-5151.147540 |
[37] |
Arita R, Fukuoka S, Mizoguchi T, et al. Multicenter study of intense pulsed light for patients with refractory aqueous-deficient dry eye accompanied by mild meibomian gland dysfunction. J Clin Med, 2020; 9, 3467. doi: 10.3390/jcm9113467 |
[38] |
Suwal A, Hao JL, Zhou DD, et al. Use of intense pulsed light to mitigate meibomian gland dysfunction for dry eye disease. Int J Med Sci, 2020; 17, 1385−92. doi: 10.7150/ijms.44288 |
[39] |
Cote S, Zhang AC, Ahmadzai V, et al. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cochrane Database Syst Rev, 2020; 3, CD013559. |
[40] |
Farrell HP, Garvey M, Cormican M, et al. Investigation of critical inter-related factors affecting the efficacy of pulsed light for inactivating clinically relevant bacterial pathogens. J Appl Microbiol, 2010; 108, 1494−508. doi: 10.1111/j.1365-2672.2009.04545.x |
[41] |
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science, 1983; 220, 524−7. doi: 10.1126/science.6836297 |
[42] |
Paranjpe V, Tan J, Nguyen J, et al. Clinical signs of meibomian gland dysfunction (MGD) are associated with changes in meibum sphingolipid composition. Ocul Surf, 2019; 17, 318−26. doi: 10.1016/j.jtos.2018.12.006 |
[43] |
Liu Y, Chen D, Chen XM, et al. Hypoxia: A breath of fresh air for the meibomian gland. Ocul Surf, 2019; 17, 310−7. doi: 10.1016/j.jtos.2018.12.001 |
[44] |
Dell SJ, Gaster RN, Barbarino SC, et al. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol, 2017; 11, 817−27. doi: 10.2147/OPTH.S130706 |
[45] |
Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology, 2017; 124, S20−6. doi: 10.1016/j.ophtha.2017.05.031 |